Skip to content

The Clinical Study of Acute Pancreatitis Treated by TongFuSan

The Clinical Study of Acute Pancreatitis With Gastrointestinal Dysfunction Treated by TongFuSan for External Application on ShenQue Acupoint

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02204189
Enrollment
100
Registered
2014-07-30
Start date
2014-03-31
Completion date
2017-02-28
Last updated
2014-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Keywords

acute pancreatitis, gastrointestinal dysfunction, TongFuSan, ShenQue acupoint

Brief summary

The purpose of this study is to determine whether TongFuSan is effective in the treatment of acute pancreatitis with gastrointestinal dysfunction.

Detailed description

* Patient who is diagnosed with acute pancreatitis(AP) should be included. * Patients will be divided into two groups as random number table: control group(A) and experimental group(B). * Group A will be given Mosapride po,and group B will be given TongFusan except for basic treatments of AP. * Same investigator will write the case report form. * Investigator will collect the patients' blood in three points: on admission, the third day and the seventh day. * Otherwise, we need write down patients' clinical manifestation,Traditional Chinese Medicine differentiation, the result of clinical tests. * When the patient discharge, we will write down the treatment measures, therapeutic effect, length of stay and the costs.

Interventions

DRUGTongFuSan

TongFuSan 1g

Sponsors

Beijing Friendship Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* clinical diagnosis of acute pancreatitis,both mild type and severe type

Exclusion criteria

* pregnant or suckling * cancer in late time * patient near death

Design outcomes

Primary

MeasureTime frame
the time of first defecationten days

Secondary

MeasureTime frame
the time of bowel sounds getting back to normalten days

Other

MeasureTime frame
Hospitalization costten days

Countries

China

Contacts

Primary ContactHong You, PHD
010-63139197
Backup ContactBin Miao, PHD
miaobin0105@126.com18612252085

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026